The Gene Therapy and In Vivo CAR T stream explores the analytical, process development, and manufacturing strategies advancing genetic medicines from development to commercial production. The CMC for In Vivo CAR T Training Seminar provides a practical foundation in analytics, process development, and potency, considerations for in vivo cell engineering using viral vectors and LNPs. The Gene Therapy CMC conference addresses BLA readiness, FDA expectations, personalized therapies, in vivo CAR T, potency, engineered capsids, and cutting-edge analytics across viral vector, LNP, and gene-edited platforms. The Gene Therapy Manufacturing conference focuses on late-stage readiness, including scale-up, upstream and downstream processing, purification, technology transfer, and process validation. Together, these programs offer practical approaches to improving yield, consistency, and quality while building scalable, cost-effective processes for reliable commercial supply.

Conferences Include: